Newly emerging data on tau protein’s role in neurodegeneration and disruption of both neurons and raises the question of whether tau protein-related pathology might be present in the early stages of the disease and contribute to early neurodegeneration in MS. The gene discussed is MAPT; the disease is myeloid sarcoma.